arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Tvardi Therapeutics, Inc.

TVRD

$1.88 ▲ +0.02 (+1.35%) at close

15 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Tvardi Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $13.9M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -100.9% ↘

FCF / Share $-3.17 ↗

Trailing P/E —

Price / Book 0.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$7.14M

↓ -66.0% —

Net Income Profit after all expenses

$-18.21M

↑ +74.3% —

Operating Margin Operating profit as % of sales

-209.1%

↑ +46.0% —

FCF / Share Free cash flow per share

$-3.17

↑ +76.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2014

FY 2015

FY 2016

FY 2017

FY 2018

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

$0.00

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	—	-66.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-925%)	-49.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-724%)	81.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+923%)	-83.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1137%)	579.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7141%)	47.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+496%)	1378.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+17131%)	959.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11891%)	-97.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1322%)	19.7% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+146%)	-73.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1018%)	905.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11217%)	—	—
EPS Growth YoY (%)	84.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	40.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-37.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	8.6% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	74.3% Excellent ↑ Excellent Improving Year-over-year change in net income	40.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-38.7% Weak Weak Year-over-year change in net income	3.4% Caution Caution Year-over-year change in net income	N/M	N/M	-43.7% Weak ↑ Weak Improving Year-over-year change in net income	-27.3% Weak ↑ Weak Improving Year-over-year change in net income	-1.5% Weak ↑ Weak Improving Year-over-year change in net income	-132.0% Weak ↓ Weak Declining Year-over-year change in net income	-39.1% Weak ↑ Weak Improving Year-over-year change in net income	-347.8% Weak Weak Year-over-year change in net income	36.8% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	76.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	35.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-18.3% Weak ↑ Weak Improving Year-over-year change in free cash flow	-23.8% Weak ↑ Weak Improving Year-over-year change in free cash flow	-863.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	95.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-310.7% Weak Weak Year-over-year change in free cash flow	64.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	-32.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-46.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	28.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	19.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	429.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	513.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	52.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-34.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-80.7% Weak Weak Compound annual revenue growth over 3 years	47.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	-18.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	9.3% Good ↓ Good Declining Compound annual revenue growth over 5 years	115.0% Excellent → Excellent Stable Compound annual revenue growth over 5 years	205.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	104.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	44.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	2.4% Caution Caution Compound annual revenue growth over 5 years	-5.2% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	—	—	—	-209.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1494%)	-386.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2679%)	4.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-73%)	—	—	—	—	—	—	-2.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-113%)	—	—
Effective Tax Rate (%) (%)	—	0.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-9.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	-204.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1801%)	-384.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3300%)	6.2% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-48%)	—	—	—	—	—	—	-33.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-376%)	—	—
FCF Margin (%) (%)	—	—	-450.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-188.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-261.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-4.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-166.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—
FCF / Net Income (x)	1.29x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-100.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1264.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-212.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	2.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-59.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-57.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-68.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-114.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	10.7% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-83.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-133.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-96.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-48.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-61.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-91.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-87.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-680%)	—	-207.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1484%)	-53.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-459%)	-38.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-359%)	3.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	-57.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-480%)	-55.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-469%)	-67.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-547%)	-112.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-853%)	-23.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-257%)	-34.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)	7.3% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	10.8% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-28%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Net Debt (USD)	$-20.73M	$-37.90M	$-51.77M	$-63.74M	$-13.45M	$-31.68M	$-18.30M	$-15.08M	$-9.39M	$-12.09M	$-15.10M	$-52.66M	$-12.36M	$-1.12M	$-4.10M

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	—	$1.56	$4.65	$9.40	$5.47	$34.33	$5.62	$4.52	$0.35	$0.04	$1.86	$1.83	$34.88	$4.34	—
Basic EPS, GAAP (USD)	$-2.46	$-15.53	$-26.26	$-19.16	$-20.96	$2.17	$-30.00	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.17	$-13.58	$-20.93	$-17.69	$-14.28	$-1.48	$-30.85	$-7.51	$-21.19	—	—	—	—	—	—
Dividend per Share (USD)	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.23	$-1.00	$12.57	$35.56	$51.26	$60.15	$48.15	$40.71	$32.01	$22.39	$46.44	$27.30	$-151.93	$-212.24	—
Tangible Book Value per Share (USD)	$2.20	$-1.00	$12.57	$35.56	$51.26	$60.15	$48.15	$40.71	$32.01	$22.39	$46.44	$27.30	$-151.93	$-212.24	—
Basic Weighted Avg Shares (shares)	7.42M	4.56M	4.51M	4.45M	4.21M	3.94M	3.54M	2.98M	2.59M	2.26M	2.04M	1.74M	343,050	273,899	—
Dividend Payout Ratio (%)	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$20.50M	$39.85M	$90.57M	$145.45M	$155.67M	$176.58M	$122.76M	$127.69M	$86.55M	$49.91M	$103.67M	$49.75M	$9.12M	—	—
Total Equity (USD)	$20.95M	$-4.59M	$57.09M	$158.78M	$227.52M	$249.00M	$186.71M	$133.63M	$86.78M	$50.73M	$105.04M	$51.66M	$-54.08M	$-58.13M	$-52.06M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	—	$7.14M	$20.97M	$41.87M	$23.03M	$135.08M	$19.89M	$13.47M	$911.00K	$86.00K	$3.80M	$3.18M	$11.96M	$1.19M	—
Depreciation Expense (USD)	$95.00K	$192.00K	$259.00K	$248.00K	$248.00K	$209.00K	$198.00K	$370.00K	$495.00K	$1.47M	$839.00K	$783.00K	$789.00K	$1.02M	—
Net Income, GAAP (USD)	$-18.21M	$-70.87M	$-118.51M	$-85.47M	$-88.44M	$8.41M	$-106.37M	$-74.01M	$-58.12M	$-57.28M	$-24.69M	$-17.75M	$-3.96M	$-6.27M	—
Operating Cash Flow (USD)	$-23.50M	$-60.92M	$-92.08M	$-78.73M	$-60.09M	$-5.49M	$-109.22M	$-22.30M	$-54.83M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 55 quarters

Tvardi Therapeutics, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TVRD with peers